Publicly Traded Cannabis Stock News

Hydroponics Retailer GrowGeneration Opens Las Vegas Store

GrowGeneration Officially Opens its 11th Store in Las Vegas and is added to MJIC’s Marijuana Index DENVER, January 20, 2017 /PRNewswire/ — GrowGeneration Corp. (OTC: GRWG), GrowGeneration (“GrowGen” or...
- January 20th, 2017 at 8:29 am

Aurora Cannabis Added More than 12,000 Patients in 2016

Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales VANCOUVER, Jan. 16, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV:...
- January 16th, 2017 at 9:01 am

Aphria Approves $137mm Expansion Project

Aphria’s Vision to be Reality – Part IV expansion project to increase greenhouse growing space to 1 million square feet Project necessary to support continued mid-term demand expectations LEAMINGTON,...
- January 16th, 2017 at 8:40 am

Canopy Growth Pays $6.6mm to Buy 42-Acre Tweed Site

Canopy Growth Triples Tweed’s Production Potential by Acquiring 1 Hershey Drive SMITHS FALLS, ON, Jan. 16, 2017 /CNW/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: CGC)...
- January 16th, 2017 at 8:00 am

Organigram Makes Key Hire to Advance Oils and Extracts Division

MONCTON, NEW BRUNSWICK–(Marketwired – Jan. 13, 2017) – Licensed medical marijuana producer Organigram Holdings Inc. (“Organigram” or the “Company”) (TSXV: OGI) (OTCQ: OGRMF) is pleased to announce the addition of...
- January 13th, 2017 at 7:49 am

Therapix Extends Ultra-Low Dose Cannabinoid Development Program

Therapix Biosciences Provides Portfolio Update TEL AVIV, Israel, January 11, 2017 /PRNewswire/ — Therapix Biosciences (OTCQB: THXBY) (TASE: THXBY.TA), a clinical-stage pharma company specializing in the development of cannabinoid-based...
- January 12th, 2017 at 2:56 pm

Canopy Growth Gets First U.S. Investment Bank Coverage

Following up on its September initiation of coverage of the cannabis industry, Cowen and Company has extended its coverage to Canada in a report entitled “O Cannabis! – Initiating...
- January 10th, 2017 at 10:42 am

Heliospectra Names New CEO, Ali Ahmadian

Heliospectra Appoints New CEO GOTHENBURG, SWEDEN and SAN FRANCISCO, CA — (Marketwired) — 01/09/17 — Heliospectra AB (OTC: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for...
- January 9th, 2017 at 11:42 am

Aphria to Invest in New Cannabis Investment Fund

Green Acre Capital Launches Investment Fund Green Acre Capital Fund to Invest Exclusively in the Legal Cannabis Industry TORONTO, Jan. 9, 2017 /CNW/ – Green Acre Capital (“GAC”) is...
- January 9th, 2017 at 8:29 am

Cannabis Science Misrepresents in Press Releases

Cannabis stocks are hot, with trading volumes remaining strong into 2017 after a 88% rise in the Cannabis Stock Index last year, with all of the gains coming after...
- January 6th, 2017 at 2:09 pm

Emblem to Raise $10mm

Emblem Corp. (TSXV: EMC) (OTC: EMMBF) announced that PI Financial will lead a group of underwriters in a bought deal. The company will be selling 2,754,821 Special Warrants for...
- January 5th, 2017 at 4:47 pm

Canopy Growth Addresses Mettrum Recall Issue

Canopy Growth Corporation Comments on the Year that was 2016 SMITHS FALLS, ON, Jan. 3, 2017 /CNW/ – As a leader in Canada’s medical cannabis industry, Canopy Growth Corporation...
- January 3rd, 2017 at 1:04 pm

GrowGeneration Hires Way To Grow Inventory Manager Joseph Prinzivalli

GrowGeneration Hires Veteran Inventory Controller Joseph Prinzivalli DENVER, January 3, 2017 /PRNewswire/ — GrowGeneration Corp. (OTCQB: GRWG), GrowGeneration (“GrowGen” or the “Company”) one of the largest specialty retail hydroponic...
- January 3rd, 2017 at 10:57 am

OrganiGram Announces Voluntary Product Recall

MONCTON, NEW BRUNSWICK–(Marketwired – Dec. 30, 2016) – Licensed medical marijuana producer Organigram Holdings Inc. (TSX VENTURE: OGI) (OTC: OGRMF) (“Organigram” or the “Company”) is voluntarily recalling certain lots...
- December 30th, 2016 at 4:25 pm

CanniMed Deal a Dud as Cannabis IPO Tanks Initially

Early trading in CanniMed Therapeutics (TSX: CMED) was disappointing, as the recent IPO broke its $12 offering price and traded below the $11.28 underwriters price. In the first half-hour...
- December 29th, 2016 at 10:18 am